Institutions Just Bought 1.3 Million Shares of XP Inc. While Call Options Surged 212% Above Normal

NEW YORK, April 14 —

On April 10, investors purchased 13,165 call options on XP Inc. (NASDAQ: XP). That's 212% above the stock's average daily volume of 4,223 call contracts. The same week, Massachusetts Financial Services disclosed it had bought 1.3 million shares. A single day of options activity triples the norm. A major institutional buyer surfaces in the same window. That's not noise. That's a thesis forming in real time.

What the Street Believes

The consensus on XP is polite but unenthusiastic. Most analysts see a well-run Brazilian brokerage stuck in a tough macro: emerging market risk premiums, the real-dollar exchange rate, and whatever Brasília decides to do with interest rates next quarter. The mean price target of $25.48 implies 21% upside from $21.06. That sounds generous until you realize the Street has been saying some version of "it'll get there eventually" for a while now. The tone is "solid company, tough neighborhood."

That framing isn't wrong, exactly. Brazil is volatile. Currency moves can erase a quarter of gains overnight for dollar-denominated investors. XP's core business — brokerage, wealth management, investment distribution — is cyclically sensitive. When Brazilian rates climb, risk appetite falls and XP's platform activity softens. The Street's discount reflects all of that.

But the consensus misses something: it treats XP like the same company it was two years ago. A Brazilian Schwab, essentially. If you're still modeling it that way, the options market and institutional flows won't make sense to you.

What the Data Actually Shows

Start with the options activity. It's the loudest signal.

"Investors purchased 13,165 call options on XP Inc., an increase of 212% compared to the average daily volume of 4,223 call options, as Massachusetts Financial Services disclosed a 1.3 million share purchase."

A 212% spike in call volume is unusual for any stock. For a mid-cap Brazilian ADR that doesn't typically generate headline-level options flow, it's a flare gun. Call buying at this scale means someone — likely multiple someones — is paying a premium for the right to buy XP shares at a fixed price in the future. That's a directional bet. The size says it isn't retail punters gambling on earnings. This is institutional positioning.

Then there's the MFS disclosure: 1.3 million shares. MFS (Massachusetts Financial Services) is one of the oldest mutual fund firms in the United States, managing hundreds of billions in assets. A purchase of that size from a shop like MFS is the result of months of internal analysis, committee approvals, and compliance reviews. This isn't a momentum trade. This is a conviction allocation.

Now add the analyst upgrades. UBS raised its target to $28 from $25. Itau BBA — one of the most-watched Brazil-focused brokerages — also raised its target. Two independent upgrades in the same window as the options spike and the MFS buy. Four data points converging in the same direction, in the same week.

Coincidences happen. Four simultaneous bullish signals from different corners of the market don't.

Why This Changes Everything

Start with the valuation arithmetic. XP trades at 1.7x forward P/E. Read that again. 1.7x. Most U.S. financial services companies trade at 10-15x forward earnings. Even heavily discounted emerging market financials typically sit at 5-8x. At 1.7x, either XP's earnings are about to collapse, or the market is pricing in a level of risk that the company's actual results contradict.

The results contradict it. XP has beaten earnings estimates three quarters running. The last three prints: $2.29 vs. $2.17 estimated (a 5.5% beat), $2.46 vs. $2.33 estimated (5.6% beat), and $2.47 vs. $2.42 estimated (2.1% beat). That's not a company in decline. It's a company consistently outperforming expectations while the stock sits at a steep discount to analyst targets.

Revenue tells the same story. XP generated $17.8bn in trailing twelve-month revenue at a 69.3% gross margin. A 69.3% gross margin is software-company territory. It reflects the leverage of a platform model — once the infrastructure exists, each incremental transaction costs almost nothing to process. This is the margin profile of a fintech, not a traditional brokerage.

Then there's the catalyst that likely explains the institutional urgency: XP's partnership with Kalshi to offer prediction markets in Brazil. XP becomes the first Brazilian financial institution to provide event contracts — a product category that barely existed five years ago and is now growing rapidly in the U.S. market.

This matters because it redefines what XP is. The Street models XP as a brokerage. Brokerages make money when people trade stocks and bonds. The Kalshi partnership means XP is expanding into an entirely different product vertical — one with higher engagement, younger demographics, and no direct competition in Latin America's largest economy. It's a TAM (total addressable market) expansion that current valuation multiples ignore entirely. Earnings models haven't been updated to include a revenue stream that didn't exist until now.

The education platform adds another layer. XP has been building financial education as a customer acquisition funnel. That's a long-duration asset: people who learn investing through your platform tend to invest through your platform. It's the same playbook that made Robinhood sticky with younger users, except XP is running it in a market where financial literacy is still a growth category.

The Bear Case

The bears have real arguments. They deserve a fair hearing.

First, Brazil. The country's interest rate environment has been brutal for growth-oriented financial platforms. When the Selic rate is elevated, Brazilian investors park money in government bonds yielding double digits. Why take equity risk when you can earn 13% risk-free in reais? That directly pressures XP's AUM growth and trading volumes.

Second, currency. XP trades as a U.S.-listed ADR. Every time the real weakens against the dollar, XP's earnings translate into fewer dollars. Even if the business is growing in local terms, FX can make the P&L look flat or worse in USD reporting. A U.S. investor buying the ADR is implicitly long the Brazilian real — a volatile bet historically.

Third, competition. Brazilian digital banks — Nu Holdings chief among them — are expanding into wealth management and brokerage. XP was the disruptor a decade ago, taking share from legacy banks. Now it risks being disrupted by companies with larger customer bases and lower acquisition costs.

Fourth, the options spike itself. Bears will argue that a single day of heavy call buying can be hedging, not directional betting. Market makers adjusting positions, structured product flows, or a single large block trade can inflate volume numbers without reflecting broad conviction.

These are all legitimate concerns. But the bear case can't explain why all four signals appeared simultaneously. Options volume alone? Maybe hedging. An MFS purchase alone? Maybe portfolio rebalancing. An analyst upgrade alone? Maybe a routine target revision. All four in the same week, while the stock sits 21% below consensus? That clustering pattern historically precedes re-ratings, not single-day pops. The bears need every signal to be a coincidence. The bulls only need one to be right.

The 1.7x forward P/E is doing real work here. At that valuation, the stock is priced as though the business is shrinking. It isn't. Three consecutive earnings beats say it's growing. The gap between price and fundamentals is wide enough that even modest upside surprises can generate outsized returns. You don't need XP to become the next great fintech story. You just need the market to stop treating it like a distressed Brazilian bank.

The Bottom Line

XP Inc. at $21 is a stock the market has filed under "Brazil, macro-dependent, come back later." The institutional activity last week says someone disagrees — strongly. A 212% call option spike, a 1.3 million share purchase by MFS, and dual analyst upgrades from UBS (target $28) and Itau BBA don't happen in a vacuum. This is coordinated conviction from people who move markets for a living.

The consensus target of $25.48 implies 21% upside from here. UBS at $28 implies 33%. Three straight earnings beats, a 69.3% gross margin, and a new revenue vertical in prediction markets that zero analysts have modeled yet — the risk/reward skews bullish. The 1.7x forward P/E gives you a margin of safety that most stocks in this market simply don't offer.

Smart money isn't waiting for the macro to clear. It's buying now, before the re-rating begins. The question for everyone else is whether the discount is a warning or an invitation. The institutional flows say invitation.

Run the free XP Inc. deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Why did XP Inc. call option volume spike 212% on April 10?

Investors purchased 13,165 call options on XP, compared to a daily average of 4,223 contracts. The spike coincided with Massachusetts Financial Services disclosing a 1.3 million share purchase, suggesting coordinated institutional positioning rather than random retail activity. Call buying at this scale typically reflects directional bullish bets from institutional players.

What is XP Inc.'s connection to Kalshi prediction markets?

XP partnered with Kalshi to become the first Brazilian financial institution to offer event contracts (prediction markets). This gives XP a new product vertical with no direct competition in Latin America's largest economy, potentially expanding its total addressable market beyond traditional brokerage and wealth management services.

How much upside do analysts see in XP Inc. stock?

The consensus price target is $25.48, implying 21% upside from the current $21.06 price. UBS recently raised its target to $28 (from $25), implying roughly 33% upside. Itau BBA also raised its target in the same period.

Has XP Inc. been beating earnings estimates?

Yes, XP has beaten estimates three consecutive quarters. The last three results: $2.29 vs. $2.17 estimated (5.5% beat), $2.46 vs. $2.33 estimated (5.6% beat), and $2.47 vs. $2.42 estimated (2.1% beat). The consistent outperformance contrasts with the stock's discounted valuation.

What are the main risks for XP Inc. investors?

The primary risks include Brazil's high interest rate environment reducing equity trading volumes, currency depreciation eroding USD-denominated returns for ADR holders, and growing competition from digital banks like Nu Holdings expanding into wealth management. The stock also carries general emerging market risk that can widen during global risk-off periods.